Your browser doesn't support javascript.
loading
Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
Stewart, Mark D; Merino Vega, Diana; Arend, Rebecca C; Baden, Jonathan F; Barbash, Olena; Beaubier, Nike; Collins, Grace; French, Tim; Ghahramani, Negar; Hinson, Patsy; Jelinic, Petar; Marton, Matthew J; McGregor, Kimberly; Parsons, Jerod; Ramamurthy, Lakshman; Sausen, Mark; Sokol, Ethan S; Stenzinger, Albrecht; Stires, Hillary; Timms, Kirsten M; Turco, Diana; Wang, Iris; Williams, J Andrew; Wong-Ho, Elaine; Allen, Jeff.
Affiliation
  • Stewart MD; Friends of Cancer Research, Washington, DC, USA.
  • Merino Vega D; Friends of Cancer Research, Washington, DC, USA.
  • Arend RC; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingam, AL, USA.
  • Baden JF; Translational Medicine, Bristol Myers Squibb, New York, NY, USA.
  • Barbash O; Oncology Experimental Medicine Unit, GlaxoSmithKline, Philadelphia, PA, USA.
  • Beaubier N; Tempus Labs, Inc., Chicago, IL, USA.
  • Collins G; Friends of Cancer Research, Washington, DC, USA.
  • French T; Global Medical Affairs, Diagnostics, AstraZeneca, Cambridge, UK.
  • Ghahramani N; Molecular Genetic Pathology Regional Laboratory, SCPMG Regional Reference Laboratories, Los Angeles, CA, USA.
  • Hinson P; Independent Cancer Research Patient Advocate, Charlotte, NC, USA.
  • Jelinic P; Early Clinical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.
  • Marton MJ; Early Clinical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.
  • McGregor K; Cancer Genomics Research Group, Foundation Medicine, Cambridge, MA, USA.
  • Parsons J; Tempus Labs, Inc., Chicago, IL, USA.
  • Ramamurthy L; Global Regulatory Affairs, GlaxoSmithKline, Washington, DC, USA.
  • Sausen M; Translational Medicine, Bristol Myers Squibb, New York, NY, USA.
  • Sokol ES; Cancer Genomics Research Group, Foundation Medicine, Cambridge, MA, USA.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Stires H; Friends of Cancer Research, Washington, DC, USA.
  • Timms KM; Myriad Genetics, Inc., Salt Lake City, UT, USA.
  • Turco D; Myriad Genetics, Inc., Salt Lake City, UT, USA.
  • Wang I; Global Precision Medicine, Novartis Pharmaceuticals Corporation, New York, NY, USA.
  • Williams JA; Precision Medicine & Biosamples, AstraZeneca, Cambridge, UK.
  • Wong-Ho E; Clinical Sequencing Division, Thermo Fisher Scientific, San Francisco, CA, USA.
  • Allen J; Friends of Cancer Research, Washington, DC, USA.
Oncologist ; 27(3): 167-174, 2022 03 11.
Article in En | MEDLINE | ID: mdl-35274707
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States